Catecholaminergic axonal varicosities appear to innervate growth hormone-releasing hormone-immunoreactive neurons in the human hypothalamus: the possible morphological substrate of the stress-suppressed growth.

作者: Giorgio Rotoli , George Grignol , Walter Hu , Istvan Merchenthaler , Bertalan Dudas

DOI: 10.1210/JC.2011-1069

关键词:

摘要: Context: Stress is considered to be a major factor in the regulation of growth. Psychosocial dwarfism, characterized with short stature, delayed puberty, and depression, typically preceded by psychological harassment or stressful environment. It has been observed that stress suppresses GH secretion, possibly via attenuation GHRH secretion. However, exact mechanism impact on growth not elucidated yet. Objective: Our previous studies revealed intimate associations between neuropeptide Y (NPY)-immunoreactive (IR) axonal varicosities GHRH-IR perikarya human hypothalamus. Because NPY molecule, NPY-GHRH juxtapositions may represent an important stress-suppressed release. In addition NPY, catecholamines are among markers stress. Thus, present study, we examined putative catecholaminergic tyrosine hydroxylase (TH)-/dopamine-β-hydroxylase-/phenylethanolamine N-methylt...

参考文章(39)
P. Saenger, Lenore S. Levine, E. Wiedemann, E. Schwartz, Sigrun Korth-Schutz, Judith Pareira, B. Heinig, Maria I. New, Somatomedin and growth hormone in psychosocial dwarfism. Pädiatrie und Pädologie. pp. 1- 12 ,(1977) , 10.1007/978-3-7091-8491-2_1
Greet Van den Berghe, Stephen M. Shalet, Critical illness as a model of hypothalamic ageing. Novartis Foundation symposium. ,vol. 242, pp. 205- 221 ,(2002) , 10.1002/0470846542.CH13
Thomas W. Uhde, Bernard Vittone, Marilla Geraci, Robert M. Post, David R. Rubinow, Jean Philippe Boulenger, Diana B. Roscow, Bruce Black, George Gurguis, Manuel E. Tancer, Evidence for hypothalamo-growth hormone dysfunction in panic disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy volunteers. Neuropsychopharmacology. ,vol. 6, pp. 101- 118 ,(1992)
S. A. BANSAL, L. A. LEE, P. D. WOOLF, Dopaminergic stimulation and inhibition of growth hormone secretion in normal man: studies of the pharmacologic specificity. The Journal of Clinical Endocrinology and Metabolism. ,vol. 53, pp. 1273- 1277 ,(1981) , 10.1210/JCEM-53-6-1273
R. STANHOPE, P. ADLARD, G. HAMILL, J. JONES, D. SKUSE, M. A. PREECE, Physiological growth hormone (GH) secretion during the recovery from psychosocial dwarfism: a case report. Clinical Endocrinology. ,vol. 28, pp. 335- 339 ,(1988) , 10.1111/J.1365-2265.1988.TB03663.X
M O Thorner, A Chait, M Aitken, G Benker, S R Bloom, C H Mortimer, P Sanders, A S Mason, G M Besser, Bromocriptine treatment of acromegaly. BMJ. ,vol. 1, pp. 299- 303 ,(1975) , 10.1136/BMJ.1.5953.299
T. Nagatsu, T. Kato, Y. Numata (Sudo), K. Ikuta, M. Sano, I. Nagatsu, Y. Kondo, S. Inagaki, R. Iizuka, A. Hori, H. Narabayashi, Phenylethanolamine N-methyltransferase and other enzymes of catecholamine metabolism in human brain Clinica Chimica Acta. ,vol. 75, pp. 221- 232 ,(1977) , 10.1016/0009-8981(77)90193-0
DIANE TALLO, WILLIAM B. MALARKEY, Adrenergic and Dopaminergic Modulation of Growth Hormone and Prolactin Secretion in Normal and Tumor-Bearing Human Pituitaries in Monolayer Culture The Journal of Clinical Endocrinology and Metabolism. ,vol. 53, pp. 1278- 1284 ,(1981) , 10.1210/JCEM-53-6-1278